US Tangential Flow Filtration Market (2025-2030)
The US Tangential Flow Filtration Market was valued at $347.9 Million in 2025 and projected to reach to $641.2 Million by 2030, representing a compound annual growth rate of 13.0%. The US tangential flow filtration market is poised for sustained expansion driven by robust biopharmaceutical manufacturing growth and increased investment in domestic production capabilities.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
US Tangential Flow Filtration Market Trends and Insights
- This 13.0% compound annual growth rate reflects strong demand across US biopharmaceutical and vaccine manufacturing sectors, where tangential flow filtration technology plays a critical role in product purification and concentration.
- The US market's expansion is driven by increasing investments in cell and gene therapy development, heightened regulatory standards for biologics, and the US pharmaceutical industry's commitment to advanced manufacturing technologies. In 2025, the US represents a significant portion of global tangential flow filtration adoption, supported by established healthcare infrastructure and leading contract manufacturing organizations.
- By 2030, the US market is expected to nearly double, driven by accelerating biosimilar production, expanded mRNA vaccine manufacturing capacity, and growing adoption in downstream processing applications.
- The US regulatory environment and FDA guidance on process validation continue to reinforce the adoption of tangential flow filtration systems across US-based manufacturers..
Key Market Statistics
- CAGR (2025-2030) 13.0% CAGR
- Market Size, 2025 ~USD 347.9 Million
- Forecast, 2030 ~USD 641.2 Million
- Country US
US Tangential Flow Filtration Market Overview
Strong US Market Valuation :
The US tangential flow filtration market is valued at $347.9 million in 2025, demonstrating significant investment in advanced purification technologies across the American biopharmaceutical sector.
Accelerated Growth Trajectory :
With a 13% CAGR through 2030, the US market is outpacing the global growth rate of 11.4%, indicating heightened adoption of tangential flow filtration in domestic manufacturing facilities.
Vaccine Manufacturing Expansion :
US vaccine production capacity has driven substantial demand for tangential flow filtration systems, particularly following increased focus on domestic biopharmaceutical self-sufficiency and pandemic preparedness.
Projected Market Expansion :
The market is forecasted to reach $641.2 million by 2030, representing a $293.3 million increase, reflecting growing adoption in cell therapy, monoclonal antibody production, and contract manufacturing organizations.
US Tangential Flow Filtration Market Dynamics
- Key drivers include rising demand for biologics, accelerated vaccine development initiatives, and regulatory emphasis on supply chain resilience.
- The 13% CAGR reflects strong adoption across major pharmaceutical hubs in California, Massachusetts, and North Carolina. Looking ahead, technological advancements in membrane materials and automation, combined with growing contract manufacturing organization (CMO) activity, will further propel market growth.
- Increasing complexity of therapeutic molecules and stringent quality standards will continue to drive adoption of tangential flow filtration systems among US manufacturers seeking efficient, scalable purification solutions..
Related Ecosystem
Biotechnology
- Reagents
- Polymerase Chain Reaction (PCR)
- Stem Cells
- Assay Kits
- Flow Cytometers
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
Key Takeaways
- The US tangential flow filtration market is valued at $347.9 million in 2025 and is forecast to reach $641.2 million by 2030, representing a 13.0% CAGR.
- US biopharmaceutical manufacturers are increasingly adopting tangential flow filtration for cell and gene therapy applications, driving market expansion.
- The US market benefits from strong regulatory support and FDA guidance that encourages adoption of advanced purification technologies in biologics manufacturing.
- By 2030, the US market is expected to nearly double in size, fueled by biosimilar production growth and expanded mRNA vaccine manufacturing capacity.
Tangential Flow Filtration Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | PES (Membrane Material) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 11.4% from 2025 to 2030 |
| Largest Segment | PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES (End User) |
| Market Size Base Year (Billions) | ~USD 1.87 (2025) |
| Revenue Forecast (Billions) | ~USD 3.2 (2030) |
| Segments Covered | Product, Type, Membrane Material, Technique, Application, Scale Of Operation, End User |
US Tangential Flow Filtration Market Report Segmentation
7 segment dimensions are covered across the global market.
By Product
- Membrane Filter Devices
- Other Products
- Systems
By Type
- Api Filtration
- Bioburden Testing
- Capsules & Cartridges
- Cassettes
- Formulation & Filling Solutions
- Media & Buffer Filtration
- Prefiltration
- Protein Purification
- Reusable Systems
- Single-Use Systems
- Vaccine & Antibody Processing
- Viral Clearance
By Membrane Material
- Mce & Ca
- Nylon
- Other Membrane Materials
- Pcte
- Pes
- Ptfe
- Pvdf
- Regenerated Cellulose
By Technique
- Microfiltration
- Nanofiltration
- Other Techniques
- Ultrafiltration
By Application
- Cell Separation
- Final Product Processing
- Raw Material Filtration
- Water Purification
By Scale Of Operation
- Manufacturing Scale Operations
- Pilot Scale Operations
- R&D Scale Operations
By End User
- Academic & Research Institutes
- Cros
- Pharmaceutical & Biotechnology Companies
US: TANGENTIAL FLOW FILTRATION MARKET, BY END USER, 2023–2030
| Segment | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| ACADEMIC & RESEARCH INSTITUTES | 49.7 | 50.3 | 51.5 | 53.9 | 57.4 | 61.9 | 67.5 | 74.4 | 7.6 |
| CROS | 62.3 | 64.7 | 68.1 | 73.3 | 80.5 | 89.7 | 101 | 115.4 | 11.1 |
| PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES | 468.8 | 494.1 | 527.4 | 576.4 | 642.4 | 725.8 | 829.8 | 961.8 | 12.8 |
| TOTAL | 580.8 | 609.1 | 646.9 | 703.6 | 780.4 | 877.5 | 998.3 | 1151.6 | 12.2 |
Target Audience
- US Biopharmaceutical Manufacturers : Need detailed market insights to evaluate tangential flow filtration technology investments, benchmark against competitors, and optimize purification processes for cost efficiency and regulatory compliance.
- Contract Manufacturing Organizations (CMOs) : Require US market data to justify capital expenditures in filtration infrastructure, assess client demand trends, and position service offerings competitively within the growing domestic outsourcing market.
- Equipment & Technology Suppliers : Depend on US-specific market intelligence to identify growth opportunities, target high-potential customer segments, and develop product strategies aligned with domestic manufacturing expansion trends.
- Private Equity & Investment Firms : Need comprehensive US market analysis to evaluate investment opportunities in biopharmaceutical manufacturing assets, assess portfolio company growth potential, and identify consolidation targets.
- Healthcare Consultants & Advisors : Utilize US market data to advise clients on manufacturing strategy, technology selection, capacity planning, and competitive positioning within the rapidly evolving American biopharmaceutical landscape.
Key Companies in the US Tangential Flow Filtration Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| FLUOR CORPORATION | United States | Public Company | Energy Solutions (traditional oil, gas, chemicals, LNG, power),Energy Transition (nuclear, low-carbon, decarbonization, CCUS, hydrogen, renewables),Urban Solutions (advanced tech, life sciences, mining, infrastructure, staffing, maintenance), |
| REPLIGEN CORPORATION | United States | Public Company | Filtration, TFF, and flow paths (XCell ATF, KrosFlo, TangenX, ProConnex, TFDF),Chromatography systems, OPUS pre-packed columns, and resins/ligands,Process analytics and PAT (PATsmart suite, SoloVPE/FlowVPE, ZipChip, REBEL), |
| PARKER-HANNIFIN CORPORATION | United States | Public Company | Hydraulic and electromechanical motion systems,Filtration, fluid conveyance, and thermal management,Sealing, adhesives, and EMI shielding, |
| ANDRITZ | Austria | Public Company | Pulp & Paper,Hydropower,Metals, |
| DONALDSON COMPANY | United States | Public Company | Mobile Solutions (off-highway, transportation, emissions and monitoring),Industrial Solutions (dust, mist, gas, compressed air, power-gen, A&D),Life Sciences (bioprocess, food & beverage, micro-environment and advanced filtration), |
FLUOR CORPORATION
Fluor Corporation is a publicly traded engineering and construction company founded in 1912 with approximately 23,000 employees. The company provides design, engineering, procurement, and construction services across multiple industries.
REPLIGEN CORPORATION
Repligen Corporation is a publicly traded United States company founded in 1981 with approximately 2,000 employees, specializing in bioprocess technologies and solutions.
PARKER-HANNIFIN CORPORATION
Parker-Hannifin Corporation is a publicly traded United States company founded in 1917 with approximately 57,950 employees, manufacturing motion and control technologies and systems.
ANDRITZ
ANDRITZ is an Austrian public company founded in 1852 with approximately 30,487 employees, providing plants, equipment, and services for various industrial sectors including pulp, paper, and environmental technologies.
DONALDSON COMPANY
Donaldson Company is a publicly traded United States company founded in 1915 with approximately 15,000 employees, manufacturing filtration systems and replacement parts.
Reasons to Buy this Report
- US-Specific Market Sizing : Obtain precise valuation data for the US market ($347.9M in 2025) with country-specific growth projections, enabling accurate budgeting and investment decisions for North American operations.
- Competitive Landscape Intelligence : Understand the competitive dynamics specific to the US biopharmaceutical manufacturing sector, including key players, market share distribution, and regional concentration patterns across major pharma hubs.
- Regulatory & Compliance Insights : Access analysis of FDA requirements, GMP standards, and US-specific regulatory drivers influencing tangential flow filtration adoption and technology selection among domestic manufacturers.
- Sector-Specific Growth Drivers : Identify high-growth segments within the US market including cell therapy, gene therapy, and mRNA vaccine production, with detailed demand forecasts through 2030.
- Strategic Investment Guidance : Leverage US market intelligence to identify expansion opportunities, partnership prospects, and technology investment priorities aligned with domestic biopharmaceutical manufacturing trends and capacity gaps.
Frequently asked questions
What is the current size of the US tangential flow filtration market?
The US tangential flow filtration market is valued at $347.9 million in 2025 and is expected to grow to $641.2 million by 2030.
What is the growth rate of the US tangential flow filtration market?
The US market is growing at a compound annual growth rate (CAGR) of 13.0% from 2025 to 2030.
Which applications are driving growth in the US tangential flow filtration market?
Key applications include cell and gene therapy manufacturing, mRNA vaccine production, biosimilar development, and downstream processing in US biopharmaceutical facilities.
Why is the US market growing faster than the global average?
The US market benefits from advanced healthcare infrastructure, strong regulatory support from the FDA, significant investment in biologics manufacturing, and a concentration of leading contract manufacturing organizations.
What factors will influence the US tangential flow filtration market through 2030?
Key factors include increased biosimilar production, expanded mRNA vaccine manufacturing capacity, growing cell and gene therapy pipelines, and continued FDA emphasis on process validation and manufacturing excellence.
RESEARCH METHODOLOGY
This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global tangential flow filtration market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the tangential flow filtration market. The secondary sources used for this study include World Health Organization (WHO), Food and Drug Administration, American Membrane Technology Associations (AMTA), American Association of Pharmaceutical Scientists (AAPS), National Institutes of Health (NIH), Pharmaceutical Research and Manufacturers of America (PhRMA), International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), European Federation of Pharmaceutical Industries and Associations (EFPIA), International Society for Pharmaceutical Engineering (ISPE), BioProcess International Magazine, BioPharm International, Journal of Bioprocessing and Biotechniques, BioPlan Associates, ScienceDirect; corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; press releases; trade, business, professional associations and among others. These sources also obtained key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
After acquiring foundational knowledge about the global tangential flow filtration market through secondary research, extensive primary research was conducted. Multiple interviews were held with market experts from the demand side, including representatives from pharmaceutical and biotechnology companies, CMOs & CROs, and academic & research institutes. Additionally, experts from the supply side were interviewed, including C-level and D-level executives, product managers, and marketing and sales managers from key manufacturers, distributors, and channel partners. These interviews spanned five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Approximately 70% of the primary interviews were conducted with supply-side participants, while the remaining 30% were with demand-side participants. The primary data was collected through various methods, including questionnaires, emails, online surveys, personal interviews, and telephone interviews.
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the tangential flow filtration market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Bottom-up Approach and Top-down Approach
The total market was split into several segments and subsegments after arriving at the overall market size from the estimation process.
Data Triangulation
After arriving at the market size from the estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Tangential flow filtration (TFF), also known as crossflow filtration, is a pressure-driven filtration technique in which a starting solution passes tangentially along the surface of a filter and a pressure difference across the filter drives components that are smaller than the pores to pass through the filter. TFF is widely used by pharmaceutical and biotechnology companies to continuously separate and purify various products. It is also used for fractionating large and small biomolecules, purification of biomolecules, harvest of cell suspensions, clarification of fermentation broths and cell lysates, and preparation of water for injection.
Stakeholders
- Filtration Product Manufacturers & Distributors
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Life Science Companies
- Venture Capitalists & Investors
- Government Organizations
- Private Research Firms
- Contract Research Organizations (CROs)
- Contract Manufacturing Organizations (CMOs)
Report Objectives
- To define, describe, and forecast the global tangential flow filtration market based on the product, membrane material, technique, application, scale of operation, end user, and region
- To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and challenges)
- To strategically analyze micro-markets concerning individual growth trends, prospects, and contributions to the overall tangential flow filtration market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments concerning six regions: North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
- To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- To track and analyze competitive developments such as acquisitions, product launches, expansions, and R&D activities in the tangential flow filtration market
- To benchmark players within the tangential flow filtration market using the ‘Company Evaluation Matrix’ framework, which analyzes market players based on various parameters within the broad categories of business & product strategy
Get the Full Tangential Flow Filtration Market Report
Full forecast, segment splits, and company analysis for all Tangential Flow Filtration Market.
- Canada Tangential Flow Filtration Market
- Germany Tangential Flow Filtration Market
- UK Tangential Flow Filtration Market
- France Tangential Flow Filtration Market
- Italy Tangential Flow Filtration Market
- Spain Tangential Flow Filtration Market
- China Tangential Flow Filtration Market
- Japan Tangential Flow Filtration Market
- India Tangential Flow Filtration Market
- South Korea Tangential Flow Filtration Market
- Australia Tangential Flow Filtration Market
- Brazil Tangential Flow Filtration Market
- Mexico Tangential Flow Filtration Market
- Rest Of Europe Tangential Flow Filtration Market
- Rest Of Asia Pacific Tangential Flow Filtration Market
- Rest Of Latin America Tangential Flow Filtration Market
- Kingdom Of Saudi Arabia (Ksa) Tangential Flow Filtration Market
- Other GCC Countries Tangential Flow Filtration Market
- United Arab Emirates (UAE) Tangential Flow Filtration Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
